戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ee interval cancers (one at the scar, two in axillae).
2 xillae), and specificity was 84.8% (84 of 88 axillae).
3      Specificity for both was 100% (15 of 15 axillae).
4  were collected from the children's mothers' axillae.
5 rodes were placed on brachial nerves in both axillae.
6 me residual sweating on the face, hands, and axillae.
7 in inflorescence meristems, and FZP in glume axillae.
8                                  Fifty-three axillae (33.5%) had at least one tumor-involved nonsenti
9 ositive lymph nodes (2.7) than true-positive axillae (5.1; P <.005).
10                            Twelve of the 208 axillae (5.8%) had stage N2 disease and two (1.0%) had s
11 vities for FNAB and CNB were 72.5% (37 of 51 axillae) and 88.2% (45 of 51 axillae), respectively (P =
12   The sensitivity for US was 61.4% (51 of 83 axillae), and specificity was 84.8% (84 of 88 axillae).
13              Samples of participants' nares, axillae, and inguinal folds were cultured to detect S au
14 tes were the abdomen, shoulders, face, head, axillae, arms, and genital region and groin.
15  vesicles and bullae around her lips, trunk, axillae, arms, and thighs.
16 nd unexpected avid radiotracer uptake in the axillae bilaterally.
17 finger/toe web spaces, volar wrists, ankles, axillae, buttocks, male genitalia, and areolae.
18 e for N2 and N3 disease was 4.1% (six of 146 axillae) for invasive ductal cancer and 17% (eight of 47
19  invasive ductal cancer and 17% (eight of 47 axillae) for invasive lobular cancer (P < .01).
20                                    Sixty-six axillae fulfilled the inclusion criteria (cortical thick
21 dular lesions or sinus tracts present in the axillae, groin, perineal, and mammillary fold regions.
22 the total study population, 45.6% (83 of 182 axillae) had metastases.
23 s, abscesses, tunnels, and scars), location (axillae, inframammary folds, groin, perigenital, or peri
24 , abscesses, and sinus tracts develop in the axillae, inguinal, and gluteal areas, typically during o
25 pose tissue in the neck and shoulder region, axillae, mediastinum, and perinephric regions.
26                               False-negative axillae on PET had significantly smaller and fewer tumor
27 bscesses and colonization of anterior nares, axillae, or inguinal folds from 2008 to 2009 at primary
28 72.5% (37 of 51 axillae) and 88.2% (45 of 51 axillae), respectively (P = .008).
29                                A total of 66 axillae underwent both FNAB and CNB.
30 ic characteristics), and patients with these axillae underwent US-guided axillary LN biopsy.
31 ed eighty-two women with clinically negative axillae were analyzed using a model treatment algorithm.
32          Imaging results from 308 assessable axillae were compared with axillary node pathology.
33 esults in 74 patients with breast cancer (75 axillae) were compared with final pathologic results.
34 nd March 2012, 178 consecutive patients (182 axillae) were evaluated by using axillary US.
35                                   Of the 208 axillae with negative findings at US, 14 (6.7%) had a fi
36 xillary metastasis but often fails to detect axillae with small and few nodal metastases.
37                               None of the 14 axillae with stage N2 or N3 disease were "triple negativ
38                                    Of the 14 axillae with stage N2 or N3 disease, eight (57.1%) had l
39 technique allows imaging of both breasts and axillae without loss of lesion contrast or temporal reso